Please login or register first to view this content.
Ophthalmic Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Olopatadine 0.7% Eye Drops Approved for Sale Over-the-Counter
Upneeq Approved for Acquired Blepharoptosis
Beovu Labeling Updated With Additional Safety Information
Eysuvis Under Review for Dry Eye Disease
Varenicline Nasal Spray Improves Signs, Symptoms of Dry Eye Disease in Trial
Low Doses of Bevacizumab Tested for Retinopathy of Prematurity
Guidance Presented for Contact Lens Use During COVID-19
Zimura Gets Fast Track Status for Geographic Atrophy Secondary to Dry AMD
Ocular Abnormalities Seen in One-Third of COVID-19 Patients
Zerviate Ophthalmic Solution Now Available for Allergic Conjunctivitis
Brolucizumab Safety Update Issued Following Reports of Ocular Events
Durysta Approved for Open-Angle Glaucoma, Ocular Hypertension
Tobradex ST Now Available for Inflammatory Eye Conditions With Bacterial Infection
FDA Approves OTC Switch of Diclofenac Gel, Olopatadine Eye Drops
Teprotumumab Bests Placebo for Active Thyroid Eye Disease
First Treatment for Thyroid Eye Disease Gets FDA Approval
The FDA Approval Process Needs Refinement, Not a Total Overhaul
FDA Panel Votes on Teprotumumab for Thyroid Eye Disease
